| 1. |
|
|
| 2. |
|
|
| 3. |
- Justtanont, K., et al.
(författare)
-
W Hya through the eye of Odin. Satellite observations of circumstellar submillimetre H2O line emission
- 2005
-
Ingår i: Astronomy and Astrophysics. - : EDP Sciences. - 0004-6361 .- 1432-0746. ; 439, s. 627-633
-
Tidskriftsartikel (refereegranskat)abstract
- We present Odin observations of the AGB star W Hya in the ground-state transition of ortho-H{2}O, 1{10}-101, at 557 GHz. The line is clearly of circumstellar origin. Radiative transfer modelling of the water lines observed by Odin and ISO results in a mass-loss rate of (2.5±0.5)×10-7 Mȯ yr-1, and a circumstellar H{2}O abundance of (2.0±1.0)×10-3. The inferred mass-loss rate is consistent with that obtained from modelling the circumstellar CO radio line emission, and also with that obtained from the dust emission modelling combined with a dynamical model for the outflow. The very high water abundance, higher than the cosmic oxygen abundance, can be explained by invoking an injection of excess water from evaporating icy bodies in the system. The required extra mass of water is quite small, on the order of 0.1 Moplus.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Justtanont, Kay, 1965, et al.
(författare)
-
W Hya through the Eye of Odin
- 2005
-
Ingår i: Astronomy & Astrophysics. ; 439, s. 627-633
-
Tidskriftsartikel (refereegranskat)
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- van Weelderen, Romy E., et al.
(författare)
-
Measurable residual disease and fusion partner independently predict survival and relapse risk in childhood KMT2A-rearranged acute myeloid leukemia : a study by the international Berlin-Frankfurt-Münster study group
- 2023
-
Ingår i: Journal of Clinical Oncology. - : American Society of Clinical Oncology (ASCO). - 0732-183X .- 1527-7755. ; 41:16, s. 2963-2974
-
Tidskriftsartikel (refereegranskat)abstract
- Purpose: A previous study by the International Berlin-Frankfurt-Münster Study Group (I-BFM-SG) on childhood KMT2A-rearranged (KMT2A-r) AML demonstrated the prognostic value of the fusion partner. This I-BFM-SG study investigated the value of flow cytometry-based measurable residual disease (flow-MRD) and evaluated the benefit of allogeneic stem-cell transplantation (allo-SCT) in first complete remission (CR1) in this disease.Methods: A total of 1,130 children with KMT2A-r AML, diagnosed between January 2005 and December 2016, were assigned to high-risk (n = 402; 35.6%) or non-high-risk (n = 728; 64.4%) fusion partner-based groups. Flow-MRD levels at both end of induction 1 (EOI1) and 2 (EOI2) were available for 456 patients and were considered negative (<0.1%) or positive (≥0.1%). End points were 5-year event-free survival (EFS), cumulative incidence of relapse (CIR), and overall survival (OS).Results: The high-risk group had inferior EFS (30.3% high risk v 54.0% non-high risk; P < .0001), CIR (59.7% v 35.2%; P < .0001), and OS (49.2% v 70.5%; P < .0001). EOI2 MRD negativity was associated with superior EFS (n = 413; 47.6% MRD negativity v n = 43; 16.3% MRD positivity; P < .0001) and OS (n = 413; 66.0% v n = 43; 27.9%; P < .0001), and showed a trend toward lower CIR (n = 392; 46.1% v n = 26; 65.4%; P = .016). Similar results were obtained for patients with EOI2 MRD negativity within both risk groups, except that within the non-high-risk group, CIR was comparable with that of patients with EOI2 MRD positivity. Allo-SCT in CR1 only reduced CIR (hazard ratio, 0.5 [95% CI, 0.4 to 0.8]; P = .00096) within the high-risk group but did not improve OS. In multivariable analyses, EOI2 MRD positivity and high-risk group were independently associated with inferior EFS, CIR, and OS.Conclusion: EOI2 flow-MRD is an independent prognostic factor and should be included as risk stratification factor in childhood KMT2A-r AML. Treatment approaches other than allo-SCT in CR1 are needed to improve prognosis.
|
|
